|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2180 USD | +9.00% |
|
+0.37% | -36.96% |
Evolution of the Average Target: Virax Biolabs Group Limited
Evolution of the Target Price: Virax Biolabs Group Limited
Changes in Analyst Recommendations: Virax Biolabs Group Limited
d86b8a53b.CEV1WTOcXlZxjTOif-yRl9iZMW2akpNvyd_cFHE6uJY.MDdENgKpaxMhyQbzK6LowYntcij5xsEgmafsUghZ9dE5JzIrVf0bOyH6eg~212bda0fd90d07742a995070b8d5375e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +400% | |||
| +26.11% | |||||
| +15.32% | |||||
| +5.68% | |||||
| +47.5% | |||||
| +21.21% | |||||
| +7.33% | |||||
| +27.53% | |||||
| +12% | |||||
| Average | +62.52% | |||||
| Weighted average by Cap. | +21.00% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2000USD
Average target price
1.000USD
Spread / Average Target
+400.00%
High Price Target
1.000USD
Spread / Highest target
+400.00%
Low Price Target
1.000USD
Spread / Lowest Target
+400.00%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| HC Wainwright |
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2000USD
Average target price
1.000USD
Spread / Average Target
+400.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VRAX Stock
- Consensus Virax Biolabs Group Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition